Arovella Therapeutics Ltd (ALA.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Sales | 136 | 17 | 406 | 296 | 257 |
| Cost of Goods | N/A | N/A | 204 | 207 | 223 |
| Gross Profit | 136 | 17 | 202 | 89 | 35 |
| Operating Expenses | 11,339 | 10,828 | 9,883 | 7,685 | 4,701 |
| Operating Income | -11,203 | -10,811 | -9,681 | -7,596 | -4,666 |
| Interest Expense | N/A | 9 | 21 | 195 | 33 |
| Other Income | 3,694 | 2,074 | -480 | -829 | -348 |
| Pre-tax Income | -7,509 | -8,746 | -10,181 | -8,621 | -5,047 |
| Net Income Continuous | -7,509 | -8,746 | -10,181 | -8,621 | -5,047 |
| Net Income | $-7,509 | $-8,746 | $-10,181 | $-8,621 | $-5,047 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| EBITDA(a) | $-11,096 | $-8,694 | $-9,324 | $-7,874 | $-4,362 |